News Archive - Life Sciences Scotland

Pneumagen Announces £4m fundraising and Commits to Clinical Trial Development for COVID-19

neumagen (Holdings) Ltd, focused on treating infectious diseases by targeting the human glycome, today announced a GBP £4 million investment to allow the clinical development of Neumifil for the prevention and treatment of COVID-19. The investment was led by Thairm...

28th May 2020

Clear

National Manufacturing Institute Scotland leadership team bolstered with CEO appointment

The National Manufacturing Institute Scotland has announced that John Reid has been appointed as Chief Executive Officer to lead the...

28th May 2020

MGB Biopharma Announces Successful Outcome from Phase II Clinical Study with MGB-BP-3 – a Potential New Gold Standard, First-Line Treatment for Clostridium difficile Infection (CDI)

MGB Biopharma, a biopharmaceutical company developing a novel class of anti-infectives, today announces that its Phase II clinical study has...

26th May 2020

Learn About Our Key Subsectors

Do you have news for the Scottish Life Sciences Community?

Submit Your Own News

News

Pneumagen Announces £4m fundraising and Commits to Clinical Trial Development for COVID-19

National Manufacturing Institute Scotland leadership team bolstered with CEO appointment

MGB Biopharma Announces Successful Outcome from Phase II Clinical Study with MGB-BP-3 – a Potential New Gold Standard, First-Line Treatment for Clostridium difficile Infection (CDI)

Amphista Therapeutics appoints leading protein degradation pioneer, Ian Churcher as CSO

Onorach’s fighting COVID-19 portal goes live

UK consortium launches COVID-19 Protein Portal to provide essential reagents for SARS-CoV-2 research

A new University of the Highlands and Islands project aims to support mental health of NHS workers

Learn About Our Key Subsectors